-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Raymond James & Associates Purchases 3,300 Shares of Cerus Co. (NASDAQ:CERS)
Raymond James & Associates Purchases 3,300 Shares of Cerus Co. (NASDAQ:CERS)
Raymond James & Associates boosted its position in Cerus Co. (NASDAQ:CERS – Get Rating) by 0.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,276,057 shares of the biotechnology company's stock after purchasing an additional 3,300 shares during the quarter. Raymond James & Associates owned approximately 0.72% of Cerus worth $7,006,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. MQS Management LLC bought a new position in Cerus in the fourth quarter worth about $69,000. WMS Partners LLC bought a new position in Cerus in the fourth quarter worth about $75,000. KBC Group NV bought a new position in Cerus in the first quarter worth about $83,000. Csenge Advisory Group bought a new position in Cerus in the first quarter worth about $86,000. Finally, Gotham Asset Management LLC bought a new position in Cerus in the fourth quarter worth about $109,000. 84.72% of the stock is currently owned by institutional investors.
Get Cerus alerts:Insider Transactions at Cerus
In other news, insider Richard J. Benjamin sold 10,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the sale, the insider now owns 172,665 shares in the company, valued at $884,044.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.33% of the company's stock.
Cerus Stock Performance
Shares of Cerus stock opened at $3.92 on Friday. Cerus Co. has a one year low of $3.90 and a one year high of $8.06. The company has a market capitalization of $694.19 million, a PE ratio of -16.33 and a beta of 1.07. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.73 and a current ratio of 2.08. The company has a 50-day simple moving average of $5.25 and a two-hundred day simple moving average of $5.19.Cerus Profile
(Get Rating)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Featured Stories
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
Raymond James & Associates boosted its position in Cerus Co. (NASDAQ:CERS – Get Rating) by 0.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,276,057 shares of the biotechnology company's stock after purchasing an additional 3,300 shares during the quarter. Raymond James & Associates owned approximately 0.72% of Cerus worth $7,006,000 at the end of the most recent reporting period.
據Raymond James&Associates提交給美國證券交易委員會的最新Form 13F文件顯示,該公司今年第一季度將其在Cerus Co.(股票代碼:CERS-GET Rating)的持倉提高了0.3%。該機構投資者在本季度額外購買了3300股後,持有這家生物技術公司1,276,057股股票。在最近一個報告期結束時,Raymond James&Associates擁有Cerus約0.72%的股份,價值7,006,000美元。
Other large investors have also added to or reduced their stakes in the company. MQS Management LLC bought a new position in Cerus in the fourth quarter worth about $69,000. WMS Partners LLC bought a new position in Cerus in the fourth quarter worth about $75,000. KBC Group NV bought a new position in Cerus in the first quarter worth about $83,000. Csenge Advisory Group bought a new position in Cerus in the first quarter worth about $86,000. Finally, Gotham Asset Management LLC bought a new position in Cerus in the fourth quarter worth about $109,000. 84.72% of the stock is currently owned by institutional investors.
其他大型投資者也增持或減持了該公司的股份。MQS Management LLC在第四季度購買了Cerus的一個新頭寸,價值約6.9萬美元。WMS Partners LLC在第四季度購買了Cerus的一個新頭寸,價值約7.5萬美元。KBC Group NV在第一季度購買了Cerus的一個新頭寸,價值約83,000美元。Csenge Consulting Group在第一季度購買了Cerus的一個新頭寸,價值約8.6萬美元。最後,Gotham Asset Management LLC在第四季度購買了Cerus的一個新頭寸,價值約10.9萬美元。84.72%的股票目前由機構投資者持有。
Insider Transactions at Cerus
Cerus的內幕交易
In other news, insider Richard J. Benjamin sold 10,000 shares of the business's stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $5.12, for a total transaction of $51,200.00. Following the sale, the insider now owns 172,665 shares in the company, valued at $884,044.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 7.33% of the company's stock.
另一則消息是,內部人士理查德·J·本傑明在一筆日期為8月9日(星期二)的交易中出售了10,000股該公司股票。該股以5.12美元的平均價格出售,總成交金額為51,200.00美元。出售後,這位內部人士現在擁有該公司172,665股,價值884,044.80美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可以通過這個超級鏈接獲得。內部人士持有該公司7.33%的股份。
Cerus Stock Performance
Cerus股票表現
Cerus Profile
CERUS輪廓
(Get Rating)
(獲取評級)
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Cerus公司是一家生物醫藥產品公司。該公司專注於開發攔截血液系統並將其商業化,以增強血液安全。其攔截血液系統,這是一項控制生物複製的專利技術,旨在減少用於輸血的捐獻血液成分中的血源性病原體。
Featured Stories
專題報道
- Get a free copy of the StockNews.com research report on Cerus (CERS)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免費獲取StockNews.com關於Cerus的研究報告(CERS)
- 隨着管理層重組,股市能否迅速反彈?
- MarketBeat:回顧中的一週8/29-9/2
- 霍梅爾在這些水平上看起來很便宜
- 露露檸檬將飆升至9月
- 耐克股票會被超賣,但仍被高估嗎?
Receive News & Ratings for Cerus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Cerus Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Cerus和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧